Literature DB >> 15498560

The C-terminal 26-residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: role of protein kinase C and CD47.

Luis Fernando Congote1, Nyssa Temmel.   

Abstract

C26, the C-terminal 26 residue peptide of serpin A1, significantly increased cell proliferation in cultures of hepatoma cells, but not in porcine kidney epithelial cells, human skin fibroblasts or keratinocytes. The mitogenic activity of C26 was preferentially inhibited with a protein kinase C (PKC) inhibitor, an antibody against CD47 and CD47 short interfering RNA. The mutant C26-K19R,N22M, imitating a thrombospondin-like cell adhesion motif, increased the mitogenic activity in both Hep G2 cells and MCF-7 breast cancer cells. Phosphorylation of C26 at T24 (a putative PKC phosphorylation site) resulted in a 1.9-2.5 increase in mitogenic activity over C26 in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498560     DOI: 10.1016/j.febslet.2004.09.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma.

Authors:  Mehdi Farshchian; Atte Kivisaari; Risto Ala-Aho; Pilvi Riihilä; Markku Kallajoki; Reidar Grénman; Juha Peltonen; Taina Pihlajaniemi; Ritva Heljasvaara; Veli-Matti Kähäri
Journal:  Am J Pathol       Date:  2011-07-01       Impact factor: 4.307

3.  Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.

Authors:  Yuhua Wang; Zhenghong Xu; Shutao Guo; Lu Zhang; Arati Sharma; Gavin P Robertson; Leaf Huang
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

4.  Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.

Authors:  Jeff S Isenberg; Douglas S Annis; Michael L Pendrak; Malgorzata Ptaszynska; William A Frazier; Deane F Mosher; David D Roberts
Journal:  J Biol Chem       Date:  2008-11-11       Impact factor: 5.157

5.  iTRAQ-based quantitative proteome and phosphoprotein characterization reveals the central metabolism changes involved in wheat grain development.

Authors:  Chaoying Ma; Jianwen Zhou; Guanxing Chen; Yanwei Bian; Dongwen Lv; Xiaohui Li; Zhimin Wang; Yueming Yan
Journal:  BMC Genomics       Date:  2014-11-27       Impact factor: 3.969

Review 6.  From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers.

Authors:  Vlad Voiculescu; Bogdan Calenic; Mihaela Ghita; Mihai Lupu; Ana Caruntu; Liliana Moraru; Suzana Voiculescu; Alexandra Ion; Maria Greabu; Nikolay Ishkitiev; Constantin Caruntu
Journal:  Dis Markers       Date:  2016-08-23       Impact factor: 3.434

7.  CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway.

Authors:  Xuejian Liu; Xia Wu; Yanming Wang; Yuhua Li; Xiangli Chen; Wenchuan Yang; Lihua Jiang
Journal:  Oncol Res       Date:  2018-01-10       Impact factor: 5.574

8.  LPCAT4 Knockdown Alters Barrier Integrity and Cellular Bioenergetics in Human Urothelium.

Authors:  Andrew S Mason; Claire L Varley; Olivia M Foody; Xiang Li; Katie Skinner; Dawn Walker; Tony R Larson; Daisuke Wakamatsu; Simon C Baker; Jennifer Southgate
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

9.  Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.

Authors:  C H Kwon; H J Park; J R Lee; H K Kim; T Y Jeon; H-J Jo; D H Kim; G H Kim; D Y Park
Journal:  Br J Cancer       Date:  2014-09-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.